Cargando…

Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States

PURPOSE: A lower daily pill burden may improve adherence to antiretroviral treatment (ART) and clinical outcomes in patients with human immunodeficiency virus (HIV). This study assessed differences in adherence using the number of pills taken per day, and evaluated how adherence correlated with hosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sax, Paul E., Meyers, Juliana L., Mugavero, Michael, Davis, Keith L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286454/ https://www.ncbi.nlm.nih.gov/pubmed/22384040 http://dx.doi.org/10.1371/journal.pone.0031591

Ejemplares similares

Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US
por: Sax, PE, et al.
Publicado: (2010)

A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States
por: Juday, Timothy, et al.
Publicado: (2011)

Association Between Prescription Cost Sharing and Adherence to Initial Combination Antiretroviral Therapy in Commercially Insured Antiretroviral-Naïve Patients with HIV
por: Johnston, Stephen S., et al.
Publicado: (2012)

Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV
por: Cohen, Calvin J, et al.
Publicado: (2013)

Association of partial adherence (PA) to antiretroviral therapy with hospitalizations and healthcare costs in an HIV population
por: Cohen, C, et al.
Publicado: (2012)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

2512. Decreasing Adherence to Antiretroviral Therapy over 4 Years of Follow-up in a Commercially-Insured Population of Patients with HIV
por: Priest, Julie, et al.
Publicado: (2019)

Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States
por: Elbur, Abubaker Ibrahim, et al.
Publicado: (2023)

Dual Trajectories of Antiretroviral Therapy Adherence and Polypharmacy in Women with HIV in the United States
por: Elbur, Abubaker Ibrahim, et al.
Publicado: (2023)

Dual trajectories of antiretroviral therapy adherence and polypharmacy in women with HIV in the United States
por: Elbur, Abubaker Ibrahim, et al.
Publicado: (2023)

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy
por: Lee, Jeannette Y., et al.
Publicado: (2016)

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2016)

Substance Use and Adherence to Antiretroviral Therapy among People Living with HIV in the United States
por: Przybyla, Sarahmona, et al.
Publicado: (2022)

Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States
por: Gold, Jeremy A. W., et al.
Publicado: (2023)

HIV Testing Trends Among Persons with Commercial Insurance or Medicaid — United States, 2014–2019
por: Henny, Kirk D., et al.
Publicado: (2021)

Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Postpartum care visits among commercially insured women in the United States
por: Butwick, Alexander J., et al.
Publicado: (2022)

Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
por: Ludwig, Cassie A., et al.
Publicado: (2023)

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States
por: McComsey, Grace A., et al.
Publicado: (2021)

Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States
por: Goodin, Douglas S., et al.
Publicado: (2014)

Presumed ocular histoplasmosis syndrome in a commercially insured population, United States
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

Retrospective Analysis of the Burden of Illness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Versus Asthma in Commercially Insured US Patients
por: Bell, Christopher F, et al.
Publicado: (2023)

Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
por: Zhao, Danni, et al.
Publicado: (2022)

Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

Forgetting to take HIV antiretroviral therapy: a qualitative exploration of medication adherence in the third decade of the HIV epidemic in the United States
por: Freeman, R., et al.
Publicado: (2021)

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage
por: Benson, Carmela, et al.
Publicado: (2020)

Economic burden related to fistulas or strictures among commercially insured patients with Crohn’s disease in the United States
por: Fan, Yanni, et al.
Publicado: (2023)

1606. Dual Trajectories of Antiretroviral Therapy Adherence and Polypharmacy in Women with HIV in the United Sate
por: SAEED, A B U B A K E R, et al.
Publicado: (2023)

Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults — United States, 2016–2021
por: Danielson, Melissa L., et al.
Publicado: (2023)

HIV Testing among Outpatients with Medicaid and Commercial Insurance
por: Dietz, Patricia M., et al.
Publicado: (2015)

Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States
por: Shea, Alisa M, et al.
Publicado: (2008)

Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States
por: Bozio, Catherine H., et al.
Publicado: (2020)

1362. Antibiotic Prescribing for Acute Otitis Media in Commercially Insured Pediatric Patients in the United States
por: Smolinski, Nicole, et al.
Publicado: (2020)

2145. Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
por: Diaz-Decaro, John D, et al.
Publicado: (2022)

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis
por: Placzek, Hilary, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1d2ecna12si3b7cr6i46padsmv